Oddity Q2 2026 slides: revenue plunges 25% amid ad disruption

Oddity reported Q2 2026 revenue of $180.5 million, down 25% year over year, while adjusted EBITDA fell 81% to $12.9 million and margin compressed 2,170bps to 7.1%. First-half adjusted EBITDA dropped 95% to $5.8 million and adjusted EPS fell 99% to $0.02, driven by advertising-algorithm disruptions at IL MAKIAGE. Management expects Q3 revenue to decline only about 5% year over year and guided FY2026 adjusted EBITDA to $30-$32 million; shares rose more than 33% premarket as investors priced in a potential stabilization. Oddity retains $561 million of cash and investments and repurchased 5.6 million shares for $80 million during the quarter.

Analysis

The key underwriting issue is not a cyclical demand trough but the fragility of a direct-to-consumer acquisition engine when a major platform changes optimization behavior. A recovery in revenue growth would not automatically restore prior earnings power: lower order values and mix deterioration imply that contribution-margin recovery must precede a credible EBITDA rerating. The premarket move therefore likely prices a rate-of-decline inflection, while the more consequential question for the next 1-3 quarters is whether IL MAKIAGE can reacquire customers at historically acceptable payback periods without materially raising marketing intensity.

ODD's cash reserve limits near-term solvency risk and makes a distressed-equity framing inappropriate, but the buyback is only value-accretive if normalized free-cash-flow conversion returns. Continued spending behind new brands could mask the core brand's unit-economics deterioration; investors should separate portfolio growth from incremental corporate profit. Larger diversified beauty peers such as EL and ULTA may benefit marginally if independent DTC brands respond to acquisition-cost volatility by reducing promotional spend, though the more relevant read-through is for digital-ad-dependent consumer brands rather than the broader beauty category.

Contrarian view: the rally may be underestimating the probability that platform-driven disruption is structural rather than a fixable execution issue. APP is worth monitoring as an indirect beneficiary only if consumer advertisers diversify budgets toward app-based performance channels, but ODD's disclosure does not establish that substitution. A sustained recovery requires sequential improvement in gross margin, marketing efficiency and free cash flow—not merely less-negative sales growth; failure on any of these would likely reintroduce multiple compression over 6-18 months.

Key Decisions for Investors

• Do not chase the opening move in ODD. Establish a 30-60 day watch position only after management discloses customer-acquisition-cost or payback-period improvement and Q3 gross margin holds near or above the Q2 level; absent those data, the thesis is a trading bounce rather than an investable turnaround.
• Tactically short ODD against a long basket of profitable beauty retail exposure (ULTA or EL) if ODD trades materially above the post-results range without a corresponding unit-economics update. Target a reversal of the event premium over 1-3 months; cover if Q3 revenue turns positive year-over-year or adjusted EBITDA guidance is raised above the stated range.
• Set an earnings alert for Q3: require evidence that sequential revenue stabilization is accompanied by positive free cash flow and limited incremental marketing spend. A revenue improvement funded by sharply higher selling expense would falsify the recovery thesis even if the headline guide is met.
• Monitor APP for evidence of increased performance-ad budgets from DTC advertisers, but take no position based on ODD alone. The necessary confirmation is APP commentary or reported advertiser-demand strength in consumer categories; without it, any linkage is speculative.